Atopic Dermatitis Clinical Trials
A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 82 clinical trials
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children with Atopic Dermatitis. This is a randomized, double-blind, Vehicle Controlled study
- 0 views
- 11 May, 2022
- 20 locations
INCB 18424-303: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1)
A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period. In the LTS period, participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream. All participants will have follow-up assessments …
- 582 views
- 10 May, 2022
- 19 locations
INCB 18424-304: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE-AD2) for 304
A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period. In the LTS period, participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream. All participants will have follow-up assessments …
- 423 views
- 03 May, 2022
- 11 locations
Integument-2 study
We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream.
- 0 views
- 04 May, 2022
- 55 locations
Integument-1 study
We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream.
- 0 views
- 04 May, 2022
- 54 locations
Integument-PED study
We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream.
- 44 views
- 17 May, 2022
- 76 locations
A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis
atopic dermatitis.
- 0 views
- 15 May, 2022
- 17 locations
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 1)
This is a 16-week study in adult participants with chronic hand eczema (CHE). The participants will visit the clinic regularly to have the study doctor assess their CHE and to answer questions
- 26 views
- 09 May, 2022
- 47 locations
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) (DELTA 2)
This is a 16-week study in adult participants with chronic hand eczema (CHE). The participants will visit the clinic regularly to have the study doctor assess their CHE and to answer questions
- 10 views
- 11 May, 2022
- 47 locations
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2 (TRuE-CHE2)
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity
- 0 views
- 12 May, 2022
- 3 locations